⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KROS News
Keros Therapeutics, Inc. Common Stock
Keros Therapeutics Announces Final Results of Tender Offer
globenewswire.com
KROS
Keros Therapeutics Announces Preliminary Results of Tender Offer
globenewswire.com
KROS
Keros Therapeutics Reports Third Quarter 2025 Financial Results
globenewswire.com
KROS
Keros Therapeutics Announces Plan for Return of $375 Million in Excess Capital
globenewswire.com
KROS
ADAR1 Sends Open Letter to Keros Board of Directors Urging the Board to Engage Constructively on Strategy, Capital Allocation and Board Refreshment
prnewswire.com
KROS